T1	Participants 939 1070	Two-hundred seven patients were enrolled between December 1, 2006 and December 14, 2007, producing 189 evaluable cases for analysis
T2	Participants 473 529	patients undergoing therapy with neurotoxic chemotherapy
T3	Participants 1707 1749	patients receiving neurotoxic chemotherapy
